Department of Pharmacy Practice, University of Illinois Chicago College of Pharmacy, Rockford, IL, United States.
Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, United States.
Curr Pharm Teach Learn. 2023 Jun;15(6):573-580. doi: 10.1016/j.cptl.2023.06.005. Epub 2023 Jun 22.
The purpose of this study is to evaluate emotional intelligence in doctor of pharmacy (PharmD) students at various points in the curriculum.
This was a cross-sectional, single site, observational study that included first- through fourth-year PharmD students, conducted from December 2021 to April 2022. The study used the Emotional Quotient Inventory, version 2.0 (EQ-i 2.0) to obtain student emotional intelligence scores. A survey in Qualtrics (SAP) was used to obtain baseline characteristics. The primary endpoint was the mean total EQ-i 2.0 scores comparing professional years. Secondary endpoints included mean EQ-i 2.0 scores in the composite scales of self-perception, self-expression, interpersonal, decision-making and stress-management. Change in EQ-i 2.0 scores was evaluated using descriptive statistics and analysis of variance. Multivariable regression analysis identified associations between baseline characteristics and EQ-i 2.0 scores.
A total of 137 (137/485, 28.2%) students completed the EQ-i 2.0 assessment. The mean (SD) total EQ-i 2.0 scores were 98.1 (15.5), 92.2 (15.9), 92.4 (12.9), and 103.5 (13.1), for first-, second- (P2), third- (P3), and fourth-year (P4) students, respectively. A statistically significant increase in total EQ-i 2.0 scores was noted in P4 students compared to P2 and P3 students. Work experience and leadership roles within student organizations may be associated with an increase in total EQ-i 2.0 scores.
Emotional intelligence varied among students in different years of the pharmacy curriculum. P4 students were found to have the highest average emotional intelligence. The effect of curricular and co-curricular components on emotional intelligence development warrants further exploration.
本研究旨在评估药学博士(PharmD)学生在课程不同阶段的情绪智力。
这是一项横断面、单站点、观察性研究,纳入了第一至第四年的 PharmD 学生,于 2021 年 12 月至 2022 年 4 月进行。该研究使用情绪商数问卷(EQ-i 2.0)获取学生的情绪智力得分。使用 Qualtrics(SAP)中的调查获取基线特征。主要终点是比较专业年限的总 EQ-i 2.0 得分均值。次要终点包括自我感知、自我表达、人际关系、决策和压力管理等综合量表的平均 EQ-i 2.0 得分。使用描述性统计和方差分析评估 EQ-i 2.0 得分的变化。多变量回归分析确定了基线特征与 EQ-i 2.0 得分之间的关联。
共有 137 名(485 名学生中的 137 名,占 28.2%)学生完成了 EQ-i 2.0 评估。第一、第二(P2)、第三(P3)和第四年(P4)学生的平均(SD)总 EQ-i 2.0 得分为 98.1(15.5)、92.2(15.9)、92.4(12.9)和 103.5(13.1)。与 P2 和 P3 学生相比,P4 学生的总 EQ-i 2.0 得分有显著增加。学生组织中的工作经验和领导角色可能与总 EQ-i 2.0 得分的增加有关。
不同药学课程阶段的学生情绪智力存在差异。P4 学生的平均情绪智力最高。课程和课外活动对情绪智力发展的影响值得进一步探讨。